AU2006272663C1 - Compositions and methods for the reduction of post-operative pain - Google Patents

Compositions and methods for the reduction of post-operative pain Download PDF

Info

Publication number
AU2006272663C1
AU2006272663C1 AU2006272663A AU2006272663A AU2006272663C1 AU 2006272663 C1 AU2006272663 C1 AU 2006272663C1 AU 2006272663 A AU2006272663 A AU 2006272663A AU 2006272663 A AU2006272663 A AU 2006272663A AU 2006272663 C1 AU2006272663 C1 AU 2006272663C1
Authority
AU
Australia
Prior art keywords
component
composition
putty
bone
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2006272663A
Other languages
English (en)
Other versions
AU2006272663B2 (en
AU2006272663A1 (en
Inventor
Richard L. Kronenthal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ORTHOCON Inc
Original Assignee
ORTHOCON Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/224,650 external-priority patent/US7955616B2/en
Application filed by ORTHOCON Inc filed Critical ORTHOCON Inc
Publication of AU2006272663A1 publication Critical patent/AU2006272663A1/en
Application granted granted Critical
Publication of AU2006272663B2 publication Critical patent/AU2006272663B2/en
Priority to AU2011200355A priority Critical patent/AU2011200355A1/en
Publication of AU2006272663C1 publication Critical patent/AU2006272663C1/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2006272663A 2005-07-25 2006-07-25 Compositions and methods for the reduction of post-operative pain Ceased AU2006272663C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2011200355A AU2011200355A1 (en) 2005-07-25 2011-01-28 Compositions and methods for the reduction of post-operative pain

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US70222605P 2005-07-25 2005-07-25
US60/702,226 2005-07-25
US11/224,650 US7955616B2 (en) 2003-09-23 2005-09-12 Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
US11/224,650 2005-09-12
US75830006P 2006-01-12 2006-01-12
US60/758,300 2006-01-12
PCT/US2006/028823 WO2007014210A2 (en) 2005-07-25 2006-07-25 Compositions and methods for the reduction of post-operative pain

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2011200355A Division AU2011200355A1 (en) 2005-07-25 2011-01-28 Compositions and methods for the reduction of post-operative pain

Publications (3)

Publication Number Publication Date
AU2006272663A1 AU2006272663A1 (en) 2007-02-01
AU2006272663B2 AU2006272663B2 (en) 2010-10-28
AU2006272663C1 true AU2006272663C1 (en) 2011-08-11

Family

ID=37683910

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2006272663A Ceased AU2006272663C1 (en) 2005-07-25 2006-07-25 Compositions and methods for the reduction of post-operative pain
AU2011200355A Abandoned AU2011200355A1 (en) 2005-07-25 2011-01-28 Compositions and methods for the reduction of post-operative pain

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2011200355A Abandoned AU2011200355A1 (en) 2005-07-25 2011-01-28 Compositions and methods for the reduction of post-operative pain

Country Status (8)

Country Link
EP (1) EP1912630A4 (ko)
JP (1) JP2009502928A (ko)
KR (1) KR20080055782A (ko)
CN (1) CN101484145A (ko)
AU (2) AU2006272663C1 (ko)
CA (1) CA2616384A1 (ko)
NZ (1) NZ563557A (ko)
WO (1) WO2007014210A2 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7955616B2 (en) 2003-09-23 2011-06-07 Orthocon, Inc. Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
CN1856283A (zh) 2003-09-23 2006-11-01 奥斯治疗有限公司 生物可吸收的油灰样止血植入体
NZ545521A (en) 2003-09-23 2010-02-26 Orthocon Inc Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
US8603528B2 (en) 2004-09-16 2013-12-10 Abyrx, Inc. Compositions and method for the reduction of post-operative pain
US20110027331A1 (en) * 2009-07-29 2011-02-03 Warsaw Orthopedic, Inc. An implantable drug depot having a reversible phase transition material for treatment of pain and/or inflammation
WO2013063585A1 (en) * 2011-10-28 2013-05-02 Baxter International Inc. Aqueous compositions for bone hemostasis, and methods for their use and manufacture
KR101852718B1 (ko) * 2017-04-04 2018-05-18 주식회사 제네웰 외과수술 후 절개부위 통증 감소를 위한 키트
CN112138203B (zh) * 2019-06-26 2022-11-08 陕西佰傲再生医学有限公司 骨止血材料

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331313B1 (en) * 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US20020090398A1 (en) * 1999-11-16 2002-07-11 Atrix Laboratories, Inc. Biodegradable polymer composition
US20030093157A1 (en) * 2001-06-29 2003-05-15 Casares Crisoforo Peralta Biodegradable injectable implants and related methods of manufacture and use
US20050113341A1 (en) * 2001-09-21 2005-05-26 Timmer Richard T. Medical devices employing triazine compounds and compositions thereof
US20050153869A1 (en) * 1997-10-23 2005-07-14 The Procter & Gamble Company Fatty acids, soaps, surfactant systems, and consumer products based thereon

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439420A (en) * 1982-11-16 1984-03-27 Ethicon, Inc. Absorbable hemostatic composition
US4568536A (en) * 1985-02-08 1986-02-04 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
NZ545521A (en) * 2003-09-23 2010-02-26 Orthocon Inc Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050153869A1 (en) * 1997-10-23 2005-07-14 The Procter & Gamble Company Fatty acids, soaps, surfactant systems, and consumer products based thereon
US6331313B1 (en) * 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US20020090398A1 (en) * 1999-11-16 2002-07-11 Atrix Laboratories, Inc. Biodegradable polymer composition
US20030093157A1 (en) * 2001-06-29 2003-05-15 Casares Crisoforo Peralta Biodegradable injectable implants and related methods of manufacture and use
US20050113341A1 (en) * 2001-09-21 2005-05-26 Timmer Richard T. Medical devices employing triazine compounds and compositions thereof

Also Published As

Publication number Publication date
WO2007014210A3 (en) 2007-10-18
AU2006272663B2 (en) 2010-10-28
CA2616384A1 (en) 2007-02-01
AU2006272663A1 (en) 2007-02-01
KR20080055782A (ko) 2008-06-19
CN101484145A (zh) 2009-07-15
JP2009502928A (ja) 2009-01-29
AU2011200355A1 (en) 2011-02-17
WO2007014210A2 (en) 2007-02-01
EP1912630A4 (en) 2012-10-03
EP1912630A2 (en) 2008-04-23
NZ563557A (en) 2011-04-29

Similar Documents

Publication Publication Date Title
US8603528B2 (en) Compositions and method for the reduction of post-operative pain
AU2004279319B2 (en) Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
US7955616B2 (en) Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
US8309131B2 (en) Absorbable putty-like implants and methods for their use for mechanical hemostasis of bone and for the treatment of osseous defects
AU2006272663C1 (en) Compositions and methods for the reduction of post-operative pain
JP2007515196A5 (ko)

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 07 FEB 2011.

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 07 FEB AND 17 MAR 2011

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired